Clinical Innovations Acquires Sandbox Medical’s SweetUms and BoogieBaby to Strengthen Leadership in Obstetrics and Neonatal Critical Care

VCBeat (WeChat ID: vcbeat) learned via Business Wire that on December 9, 2019, medical device company Clinical Innovations announced the acquisition of two market-leading products from SandBox Medical: SweetUms sucrose solution and BoogieBaby oral and nasal suction devices. It is reported that these two product lines are primarily sold in the United States.

Clinical Innovations, founded in 1993 and headquartered in Murray, Utah, USA, is an EQT portfolio company and one of the world’s largest medical device companies. It specializes in clinical equipment innovations for labor and delivery as well as the neonatal intensive care unit (NICU). The company’s product portfolio includes the Koala intrauterine pressure catheter, the Kiwi vacuum-assisted delivery system, ROMPlus for detecting rupture of membranes, the traxi Panniculus retractor, the ClearView uterine manipulator, and the babyLance safety heel incisor.

In recent years, Clinical Innovations has expanded rapidly worldwide and continuously ventured into new fields, while establishing commercial organizations in developed markets such as the United States, Western Europe, Australia, and China. The company’s clinical innovation devices are distributed across more than 90 countries and regions globally, with hospitals in the United States and Western Europe accounting for 85% of its market share.

Currently, the company is expanding its global footprint while researching and developing cutting-edge technologies and innovative medical devices to fulfill its mission of improving the lives of mothers and their babies worldwide. The new products from this acquisition will enable Clinical Innovations to better serve pediatricians around the globe.

SandBox Medical, founded in 2009 and headquartered in Pembroke, Massachusetts, USA, is a pediatric healthcare company. Its SweetUms 24% sucrose solution helps soothe and calm infants in distress. Sucrose, as a non-pharmacological intervention, has been extensively studied within the industry and statistically and clinically proven to significantly alleviate infant discomfort. BoogieBaby is a single-use cavity suction device specially designed by researchers, offering models for ten specific clinical scenarios. Both products were launched in 2015 and are currently used by approximately 1,500 hospitals, demonstrating double-digit growth in recent years.

Ken Reali, President and Chief Executive Officer of Clinical Innovations, stated, “Our mission is to improve the lives of mothers and babies worldwide. Adding SweetUms and BoogieBaby to our product portfolio will strengthen our leadership in the obstetrics and neonatal intensive care unit markets. Our sales team will continue to drive market penetration for these two leading products.”

Read McCarty, co-founder of SandBox Medical, said, “Our entire team is thrilled. Through Clinical Innovations’ acquisition, SweetUms and BoogieBaby will be able to benefit more newborns worldwide.”

“Clinical Innovations aligns with our core values and possesses the specialized expertise to expand the market reach of SweetUms and BoogieBaby. We look forward to seeing these two products continue to thrive under the leadership of Ken’s team,” said Eileen Gay, Co-founder, General Manager, and Partner at SandBox Medical.

(Compiled by Jiang Ying)